ArticleCurrent medical science2024

Silencing MFN2 Drives WNT/β-catenin Nucleation to Reduce Sorafenib Sensitivity in Hepatocellular Carcinoma Cells.

Chai-Ming Zeng et al.PubMed ↗Publisher ↗

No numbers read from the abstract.